J. Stark Thompson PhD - 29 Jul 2021 Form 3 Insider Report for MAXCYTE, INC. (MXCT)

Reporting relationship
Director
Issuer ticker
MXCT
Reported as of
29 Jul 2021
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
29 Jul 2021, 18:45:05 UTC
Next SEC filing
11 Aug 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Minio, Attorney-in-Fact

Key filing fact

J. Stark Thompson PhD filed Form 3 for MAXCYTE, INC. (MXCT) on 29 Jul 2021.

Key facts

  • This page summarizes J. Stark Thompson PhD's Form 3 filing for MAXCYTE, INC. (MXCT).
  • 0 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 29 Jul 2021, 18:45.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MXCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
110,918
Date
29 Jul 2021
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MXCT holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
89,333
Exercise price
$0.0400
Footnotes
F1
MXCT holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,400
Exercise price
$1.12
Footnotes
F1, F2
MXCT holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,900
Exercise price
$3.33
Footnotes
F1, F2
MXCT holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,900
Exercise price
$3.34
Footnotes
F2, F3
MXCT holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
26,900
Exercise price
$2.44
Footnotes
F2, F4
MXCT holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
26,900
Exercise price
$1.87
Footnotes
F2, F5
MXCT holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
26,900
Exercise price
$14.30
Footnotes
F2, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

This option is fully vested and exercisable.

Footnote F2

This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of GBP 1.00 to $1.3749 as of July 23, 2021.

Footnote F3

The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on August 18, 2018, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Footnote F4

The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Footnote F5

The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Footnote F6

One hundred percent (100%) of the shares underlying this option shall vest on January 13, 2022, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .